BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28964747)

  • 1. Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial.
    Park CH; Jung JH; Hyun B; Kan HJ; Lee J; Kae SH; Jang HJ; Koh DH; Choi MH; Chung MJ; Bang S; Park SW
    Gastrointest Endosc; 2018 Apr; 87(4):1040-1049.e1. PubMed ID: 28964747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis.
    Lv ZH; Kou DQ; Guo SB
    BMC Gastroenterol; 2020 Apr; 20(1):118. PubMed ID: 32306904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis.
    Sutton VR; Hong MK; Thomas PR
    JOP; 2011 Jul; 12(4):372-6. PubMed ID: 21737899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Kobayashi K; Sasaki T; Serikawa M; Inoue M; Itsuki H; Chayama K
    Pancreas; 2011 Nov; 40(8):1206-10. PubMed ID: 21792081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis in Children With Chronic Pancreatitis and Its Prediction Using 4-Hour Postprocedure Serum Amylase and Lipase Levels.
    Samanta A; Vadlapudi SS; Srivastava A; Mohindra S; Sen Sarma M; Poddar U; Saraswat VA; Mishra P
    Pancreas; 2024 Mar; 53(3):e247-e253. PubMed ID: 38227737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
    Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis.
    Testoni PA; Bagnolo F
    Gastrointest Endosc; 2001 Jan; 53(1):33-9. PubMed ID: 11154486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.
    Papachristos A; Howard T; Thomson BN; Thomas PR
    ANZ J Surg; 2018 Jan; 88(1-2):82-86. PubMed ID: 27457275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
    Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
    Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial.
    Mariani A; Di Leo M; Giardullo N; Giussani A; Marini M; Buffoli F; Cipolletta L; Radaelli F; Ravelli P; Lombardi G; D'Onofrio V; Macchiarelli R; Iiritano E; Le Grazie M; Pantaleo G; Testoni PA
    Endoscopy; 2016 Jun; 48(6):530-5. PubMed ID: 26990509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.
    Ito K; Fujita N; Noda Y; Kobayashi G; Horaguchi J; Takasawa O; Obana T
    World J Gastroenterol; 2007 Jul; 13(28):3855-60. PubMed ID: 17657841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.